Cite
HARVARD Citation
Ruiz‐Garcia, A. et al. (2021). Evaluation of the Relationship of Glasdegib Exposure and Safety End Points in Patients With Refractory Solid Tumors and Hematologic Malignancies. Journal of clinical pharmacology. pp. 349-359. [Online].